WHO ICTRP trial
Observational study to determine the type of patient with cervical dystonia that…
ACTRN12609000800224 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12609000800224 |
|---|---|
| Public title | Observational study to determine the type of patient with cervical dystonia that responds best to botulinum toxin treatment |
| Scientific title | An international observational study to define factors influencing response to one Botulinum Toxin Type A (BoNT-A) injection cycle in subjects suffering from idiopathic cervical dystonia. |
| Primary sponsor | Ipsen |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Idiopathic Cervical Dystonia; Idiopathic Cervical Dystonia;Neurological - Other neurological disorders |
| Interventions | Botulinum Toxin Type A (BoNT-A) for idiopathic cervical dystonia. BoNT-A is able to stop nerves stimulating muscles thus providing a way of relaxing muscles. BoNT-A is administered by intramuscular injections with a duration of action of… |
| Registration date | Sep 15, 2009 |
| Target size | 40 |
| Secondary IDs | Y-79-52120-131. Ipsen. |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: